Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax.
Lee-Or HerzogBeth WaltersRoberta BuonoJ Scott LeeSharmila MallyaAmos FungHonyin ChiuNancy NguyenBoyang LiAnthony B PinkertonMichael R JacksonRobert J SchneiderZe'ev A RonaiDavid A FrumanPublished in: British journal of cancer (2020)
Our data highlight a novel combination for treatment of aggressive lymphomas, and establishes its efficacy and selectivity using preclinical models.